Institut Curie

Institut Curie is a research organisation in Paris, France that has taken part in 218 EU-funded projects since 2008, receiving €126M in EU funding and leading 103 as coordinator.

EU funding received€126M
EU projects218
As coordinator103
Running now50
First EU project2008
Latest project2027
CountryFrance
EU registration (PIC)999896759
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Institut Curie's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€60.1M · 78 projects
  • Horizon 2020€44.7M · 84 projects
  • Horizon Europe€20.0M · 45 projects
  • EU4Health Programme (EU4H)€874k · 8 projects
  • Digital Europe Programme (DIGITAL)€150k · 1 project
  • 3rd Health Programme€49k · 1 project
  • Erasmus+ (ERASMUS+)€0 · 1 project

Projects

218 EU-funded projects, newest first. Institut Curie led 103 of them as coordinator. Each links to the official record.

  • Vax4eUPartner

    Vaccinologists for Europe: Training network for developing next generation vaccines against mucosal pathogens

    Horizon Europe · 2027–2031 · Project on CORDIS ↗

    €315ktheir share
  • 3DCellIDCoordinator

    How 3D genome organization allows cells to learn and remember their identity

    Horizon Europe · 2026–2028 · Project on CORDIS ↗

    €242ktheir share
  • M4GIC-ILCPartner

    ​Multi-modal, Multi-site, Multi-omic, Multi-AGent AI framework for the Clinical management of ILC

    Horizon Europe · 2026–2029 · Project on CORDIS ↗

    €796ktheir share
  • SCAILEDPartner

    Scale-up biotech AI innovation by leveraging responsible data use under the European Health Data Space

    EU4Health Programme (EU4H) · 2026–2029 · Project on the EU portal ↗

    €29ktheir share
  • PEDGLIORESCoordinator

    DECIPHERING MECHANISMS OF RESISTANCE TO TARGETED THERAPY IN PAEDIATRIC GLIOMA

    Horizon Europe · 2026–2028 · Project on CORDIS ↗

    €226ktheir share
  • THEODORACoordinator

    immunoTHErapies targeting neOgenes in paeDiatric and adOlescent saRcomAs

    Horizon Europe · 2026–2032 · Project on CORDIS ↗

    €3.7Mtheir share
  • PHOENIXPartner

    Phase I/II trial of an Oral ER-stress iNducer in relapsed/refractory neuroblastoma and paediatric solid tumours

    Horizon Europe · 2026–2032 · Project on CORDIS ↗

    €281ktheir share
  • RADNEXT 2030Partner

    Accelerators and other Research Infrastructures for Radiation Effects Research

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

    €189ktheir share
  • TranStructRxCoordinator

    Targeting mRNA Structure to Control Translation with Small Molecules

    Horizon Europe · 2026–2028 · Project on CORDIS ↗

    €242ktheir share
  • CenAGEAssociated partner

    CenAGE, a 'Centromeric' view on AGEing: unveiling centromere instability in ageing

    Horizon Europe · 2026–2032 · Project on CORDIS ↗

  • PatCorgPartner

    Spatially patterned organoids: regionalization, cell fate and lamination in cortical development and neuronal migration disorders

    Horizon Europe · 2026–2031 · Project on CORDIS ↗

    €1.9Mtheir share
  • GlioZEROPartner

    Advanced technologies for zeroing in on high-grade gliomas

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

    €95ktheir share
  • DCsConCargoCoordinator

    Investigating DC migration with large, ingested cargos through confining environments

    Horizon Europe · 2026–2028 · Project on CORDIS ↗

    €242ktheir share
  • GeneMotorsPartner

    Genome control by DNA-looping motors: from folding to function

    Horizon Europe · 2026–2032 · Project on CORDIS ↗

    €833ktheir share
  • Partner4VRTPartner

    Enhanced International Research on Very Rare Cancers of Paediatric & Adolescent and Young Adult Age: The Collaborative Observational Study for Pancreatoblastoma and Adrenocortical Carcinoma

    EU4Health Programme (EU4H) · 2026–2027 · Project on the EU portal ↗

    €20ktheir share
  • IGNITIONAssociated partner

    Controlling cell lineage integrity to intercept tumor initiation

    Horizon Europe · 2025–2030 · Project on CORDIS ↗

  • JA PCMAssociated partner

    Joint Action Personalised Cancer Medicine

    EU4Health Programme (EU4H) · 2025–2029 · Project on the EU portal ↗

    €52ktheir share
  • Bio3XBRITCoordinator

    Unraveling mechanisms of immunotherapy resistance through biomarker profiling in triple-negative breast cancer

    Horizon Europe · 2025–2027 · Project on CORDIS ↗

    €226ktheir share
  • BREATHAssociated partner

    Boosting future REsearchers in biomaterials for Advanced healTH solutions

    Horizon Europe · 2025–2030 · Project on CORDIS ↗

  • Stem2MorphoMapCoordinator

    Deciphering the interplay between stem cell differentiation and stem cell dynamics in branching morphogenesis

    Horizon Europe · 2025–2027 · Project on CORDIS ↗

    €196ktheir share
  • TE-TimeCoordinator

    Dissecting host-transposon interactions during germline development and their impact on genome integrity

    Horizon Europe · 2025–2027 · Project on CORDIS ↗

    €196ktheir share
  • CHROMOGENEVOAssociated partner

    The impact of chromatin on genome organisation, function and evolution

    Horizon Europe · 2025–2030 · Project on CORDIS ↗

  • AxTransCodeCoordinator

    Determining the role of tubulin polyglutamylation in the regulation of neuronal functions

    Horizon Europe · 2025–2027 · Project on CORDIS ↗

    €242ktheir share
  • PREDI-LYNCHPartner

    Validated non-invasive liquid biopsy tests for cancer PREDIction in LYNCH Syndrome

    Horizon Europe · 2025–2031 · Project on CORDIS ↗

    €196ktheir share
  • SHAIPEDPartner

    Supporting Health Data Access Bodies to establish AI pathways enabling Deployment of AI as medical device tools

    Digital Europe Programme (DIGITAL) · 2025–2028 · Project on the EU portal ↗

    €150ktheir share
  • GRASSHOPPERPartner

    The GRASSHOPPER network: Jumping forward from preclinical development of pediatric cancer drugs to clinical implementation

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

    €166ktheir share
  • CrowdControlCoordinator

    CrowdControl: Identifying the mechanism underlying intracellular density homeostasis.

    Horizon Europe · 2024–2027 · Project on CORDIS ↗

    €333ktheir share
  • SERPAssociated partner

    Erasmus Mundus Joint Master's programme in Surface, Electro, Radiation, and Photo-chemistry

    Erasmus+ (ERASMUS+) · 2024–2030 · Project on the EU portal ↗

  • EUnetCCC JAAssociated partner

    The European Comprehensive Cancer Centre Network

    EU4Health Programme (EU4H) · 2024–2028 · Project on the EU portal ↗

    €401ktheir share
  • MAIT-TraDeCoordinator

    Development and trafficking of type 1 and type 17 mucosal-associated invariant T cells

    Horizon Europe · 2024–2026 · Project on CORDIS ↗

    €196ktheir share
  • DynamyeloAssociated partner

    Quantifying cell dynamics in myelopoiesis during immune responses

    Horizon Europe · 2024–2029 · Project on CORDIS ↗

  • ArturoCoordinator

    Assessing the role of intratumoral microbiota in therapy responses using patient-derived tumor-on-chip

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

    €2.5Mtheir share
  • MyoDuoCoordinator

    Force production of myosin 18 and its molecular sociology with myosin 2

    Horizon Europe · 2024–2026 · Project on CORDIS ↗

    €202ktheir share
  • MONALISAPartner

    A SIOPEN pragmatic clinical trial to MOnitor NeuroblastomA relapse with LIquid biopsy Sensitive Analysis

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

    €786ktheir share
  • CERTAINTYPartner

    A CEllulaR immunoTherapy virtuAl twin for personalIsed cancer treatmeNT

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €436ktheir share
  • INTERACT-EUROPE 100Partner

    INTERACT-EUROPE 100

    EU4Health Programme (EU4H) · 2023–2026 · Project on the EU portal ↗

    €18ktheir share
  • PACT4EYEPartner

    Innovative Photoactivated Ruthenium Chemotherapy to treat eye cancer

    Horizon Europe · 2023–2026 · Project on CORDIS ↗

    €472ktheir share
  • ERN PaedCan-Y7-Y10Partner

    European Reference Network on Paediatric Cancer

    EU4Health Programme (EU4H) · 2023–2027 · Project on the EU portal ↗

    €133ktheir share
  • ReGutBMCoordinator

    Regulation of epithelial-cells renewal by basement membrane protein composition and stiffness during gut homeostasis

    Horizon Europe · 2023–2025 · Project on CORDIS ↗

    €212ktheir share
  • STEMGUARDCoordinator

    Deciphering stem cell immunity

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €1.5Mtheir share
Show 40 more projects
  • ARTiDePartner

    Autoantigen-specific adoptive regulatory T cell therapy against type 1 diabetes (ARTiDe)

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €225ktheir share
  • RT-SuperESPartner

    Real-Time high-content Super-Resolution Imaging of ES Cell States

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €549ktheir share
  • HOTIMAGEPartner

    HOst-Transposon Interactions in the MAle GErmline

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €833ktheir share
  • CCI4EUPartner

    COMPREHENSIVE CANCER INFRASTRUCTURES 4 EUROPE

    Horizon Europe · 2023–2026 · Project on CORDIS ↗

    €150ktheir share
  • SHAPINCELLFATEAssociated partner

    Impact of cell shapes on cell behaviour and fate

    Horizon Europe · 2023–2029 · Project on CORDIS ↗

  • RBP-ReguNetPartner

    Deconstructing and Rewiring RNA-RBP regulatory networks

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €283ktheir share
  • Maxima ButterflyAssociated partner

    From Caterpillar to BUTTERFLY: supporting transformation of DCs in a paediatric oncology network

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

  • EUonQoLPartner

    Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe

    Horizon Europe · 2023–2026 · Project on CORDIS ↗

    €152ktheir share
  • MELCAYAAssociated partner

    Novel health care strategies for melanoma in children, adolescents and young adults

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

  • EVCAPartner

    Centre for Excellence in Diagnostic and Advanced Therapeutics based on Extracellular Vesicles

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

    €360ktheir share
  • CAN.HEALPartner

    Building the EU Cancer and Public Health Genomics platform

    EU4Health Programme (EU4H) · 2022–2025 · Project on the EU portal ↗

    €213ktheir share
  • GlioSurgCoordinator

    Role of astrogliosis in the recurrence of brain tumors after microsurgical resection

    Horizon Europe · 2022–2024 · Project on CORDIS ↗

    €210ktheir share
  • CellinfoCoordinator

    Quantification of information flow in a cell signaling pathway

    Horizon 2020 · 2022–2024 · Project on CORDIS ↗

    €185ktheir share
  • RELEVIUMPartner

    Improving quality of life of advanced pancreatic cancer patients through an AI-guided multimodal intervention, combining pain and cachexia management, nutrition, and physical activity

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

    €200ktheir share
  • TargetBRCACoordinator

    To develop a new targeted therapy for the treatment of naive and PARP inhibitor-resistant BRCA1/2-mutated tumors

    Horizon Europe · 2022–2024 · Project on CORDIS ↗

    €150ktheir share
  • INTERACT-EUROPEPartner

    Innovative collaboration for Inter-specialty cancer training across Europe

    EU4Health Programme (EU4H) · 2022–2023 · Project on the EU portal ↗

    €9ktheir share
  • XCYCLEAssociated partner

    Toward a comprehensive analysis of the dynamics and mechanisms of X chromosome inactivation in Humans

    Horizon 2020 · 2021–2027 · Project on CORDIS ↗

  • PROTECT-trialPartner

    Proton versus Photon Therapy for Esophageal Cancer - a Trimodality Strategy

    Horizon 2020 · 2021–2027 · Project on CORDIS ↗

    €5ktheir share
  • Fas_Life-DeathCoordinator

    A Biophysical Investigation of the Duality in Fas Receptor

    Horizon 2020 · 2021–2023 · Project on CORDIS ↗

    €185ktheir share
  • ChromTraceAssociated partner

    Tracing epigenetic evolution of triple-negative breast cancer towards chemo-resistance

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

  • VAGABONDPartner

    Validation of Actionable Genomic ABerrations in a paediatric Oncology Network for Doctorate students

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €550ktheir share
  • EuReCaCoordinator

    Institut Curie EuReCa PhD Programme

    Horizon 2020 · 2020–2027 · Project on CORDIS ↗

    €3.2Mtheir share
  • KILL-OR-DIFFERENTIATAssociated partner

    Using cell-cell interactions to unlock new cancer treatments: Forcing neural crest tumors back onto the developmental path

    Horizon 2020 · 2020–2027 · Project on CORDIS ↗

  • MAITCoordinator

    Tissue repair functions of MAIT cells: integrating thymic pre-commitment and peripheral signals

    Horizon 2020 · 2020–2025 · Project on CORDIS ↗

    €2.5Mtheir share
  • PerMedCoEPartner

    HPC/Exascale Centre of Excellence in Personalised Medicine - PerMedCoE

    Horizon 2020 · 2020–2023 · Project on CORDIS ↗

    €509ktheir share
  • GrowthDevStabilityCoordinator

    Characterization of the developmental mechanisms ensuring a robust symmetrical growth in the bilateral model organism Drosophila melanogaster

    Horizon 2020 · 2020–2022 · Project on CORDIS ↗

    €185ktheir share
  • IMPEDCoordinator

    INTEGRATED MICROFLUIDIC PLATFORM FOR PROTEOMIC AND GENETIC EXOSOME DETECTION

    Horizon 2020 · 2020–2023 · Project on CORDIS ↗

    €225ktheir share
  • MIMICCoordinator

    Deciphering how microbiota modulate anti-tumor immune responses in checkpoint therapy

    Horizon 2020 · 2020–2022 · Project on CORDIS ↗

    €185ktheir share
  • PROSTATORCoordinator

    Reliable urinary test for the diagnosis of prostate cancer

    Horizon 2020 · 2020–2021 · Project on CORDIS ↗

    €150ktheir share
  • oncNGSPartner

    NGS diagnostics in 21st century oncology: the best, for all, at all times

    Horizon 2020 · 2020–2026 · Project on CORDIS ↗

    €300ktheir share
  • NEUcrestCoordinator

    Training European Experts in Multiscale Studies of Neural Crest Development and Disorders: from Patient to Model Systems and Back again.

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

    €550ktheir share
  • Cell2CellPartner

    What makes a successfull pathogen? Understanding the impact of cell-to-cell heterogeneity in chromatin structure on infection and adaptation

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

    €275ktheir share
  • RNAfateCoordinator

    RNAfate- revealing regulation of cellular “noise”.

    Horizon 2020 · 2019–2021 · Project on CORDIS ↗

    €173ktheir share
  • THERADNETPartner

    International NETwork for training and innovations in THErapeutic RADiation

    Horizon 2020 · 2019–2023 · Project on CORDIS ↗

    €550ktheir share
  • VESSEL CO-COPTIONCoordinator

    Vessel co-option and radioresistance in glioblastoma

    Horizon 2020 · 2019–2025 · Project on CORDIS ↗

    €1.5Mtheir share
  • ARCHPartner

    AGE-RELATED CHANGES IN HEMATOPOIESIS

    Horizon 2020 · 2019–2023 · Project on CORDIS ↗

    €275ktheir share
  • LifeTimePartner

    Revolutionizing Healthcare by Tracking and Understanding Human Cells during Disease

    Horizon 2020 · 2019–2020 · Project on CORDIS ↗

    €266ktheir share
  • IMMUcanPartner

    Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts

    Horizon 2020 · 2019–2026 · Project on CORDIS ↗

    €510ktheir share
  • incPRINT-DRUGCoordinator

    incPRINT as a platform for RNA-targeted drug discovery

    Horizon 2020 · 2019–2021 · Project on CORDIS ↗

    €150ktheir share
  • EJP RDAssociated partner

    European Joint Programme on Rare Diseases

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

Showing the 80 most recent of 218 projects.

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA
  • DNA viruses
  • HIV
  • RNA
  • RNA viruses
  • additive manufacturing
  • alkali metals
  • allergology
  • alzheimer
  • amorphous semiconductors
  • amyotrophic lateral sclerosis
  • anatomy and morphology
  • antibiotic resistance
  • antibiotics

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime